Dianthus Therapeutics
Price & Volume
Stats
See more52W Range | $13.36-$44.95 |
Market Cap | $1.8B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $3M |
Revenue Growth (YoY) | -81.8% |
Gross Profit (12 Mos) | $3M |
Diluted EPS | -$3.50 |
News
See moreYahoo Finance • 24 days ago
Dianthus Therapeutics GAAP EPS of -$0.97
Yahoo Finance • 24 days ago
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Yahoo Finance • last month
Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting
Yahoo Finance • last month
Dianthus to license autoimmune disease candidate in a deal worth up $1B
About
CEO | Mr. Marino Garcia M.B.A. |
Address | 7 Times Square, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 78 |
